Haemonetics Corporation (NYSE:HAE) Q1 2023 Earnings Conference Call August 10, 2022 8:00 AM ET
Company Participants
Olga Guyette - Director, IR and Treasury
Chris Simon - CEO
James D’Arecca - CFO
Conference Call Participants
Larry Solow - CJS Securities
Drew Ranieri - Morgan Stanley
Andrew Cooper - Raymond James
Mike Matson - Needham & Company
Michael Petusky - Barrington Research
David Turkaly - JMP Securities
Anthony Petrone - Mizuho Securities
Operator
Good day, and welcome to Haemonetics Corporation's First Quarter Fiscal 2023 Earnings Call. [Operator Instructions] As a reminder, this call is being recorded.
I would like to turn the call over to Olga Guyette, Senior Director of Investor Relations and Treasury. You may begin.
Olga Guyette
Good morning, everyone. Thank you for joining us for Haemonetics' first quarter fiscal '23 conference call and webcast. I'm joined today by Chris Simon, our CEO; and James D’Arecca, our CFO.
This morning, we posted our first quarter fiscal '23 results to our Investor Relations website, along with updates for fiscal '23 guidance in analytical tables with information that we'll refer to on this call. Additionally, we provided a complete P&L, balance sheet, summary statement of cash flows as well as reconciliations of our GAAP to non-GAAP financial results and guidance.
Before we get started, unless otherwise noted, all revenue growth rates discussed today are on an organic basis and exclude the impact of currency fluctuation and strategic exits of product lines. As in the past, we will refer to non-GAAP financial measures to help investors understand Haemonetics' ongoing business performance. Please note that these measures exclude certain charges and income items. Please refer to this morning's earnings release for details on excluded items, including comparisons with the same periods of fiscal '22 and a reconciliation to our GAAP results.
Our remarks today include forward-looking statements, and our actual results may differ materially from the anticipated results. Haemonetics cautions that these forward-looking statements are subject to risks and uncertainties, including the potential impacts from the pandemic on our results and other factors referenced in the Safe Harbor statement in our earnings release and our filings with the SEC. We do not undertake any obligation to update these forward-looking statements. Additionally, in order to protect customer confidentiality, we will not be able to discuss any customer specific details except as disclosed previously.
And now I'd like to turn it over to Chris.
Chris Simon